ZOETIS INC. (ZTS)
What changed this quarter
- Risk factors — 4 added · 2 removed · new: Changes in trade policies, including the im… +3
- Free cash flow declined recently
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Company overview
Zoetis. The world's No. 1 in animal medicine. It supplies vaccines and drugs for pets and livestock, maintaining stable growth.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
ZOETIS INC. is classified under the Biotech & Health sector. See peers below.
ZOETIS INC. key financials
Based on SEC filings · latest quarter (TTM)
Tap a metric name to see its meaning in the glossary.
ETFs holding ZOETIS INC.
Per SEC N-PORT · 2026-03-31 · by weight · factual
ZTS on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — valuation and growth vs the Biotech & Health average
Peers · Biotech & Health
ZTS FAQ
What is ZOETIS INC. (ZTS)?
Zoetis. The world's No. 1 in animal medicine. It supplies vaccines and drugs for pets and livestock, maintaining stable growth.
What sector is ZOETIS INC. in?
ZOETIS INC. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are ZOETIS INC.'s key financials?
Based on the latest quarter (TTM) from SEC filings: Revenue growth (YoY) 2.6%, Net margin 27.8%, ROE 80.2%, Debt-to-equity 2.71x. Definitions and interpretation are available on Stocklore.
Where can I analyze ZOETIS INC. (ZTS) stock?
On Stocklore you can see ZTS's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, 45-day delay), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.